Skip to main content
Livermore
Livermore
ZHEN

Kaleido Biosciences, Inc.

KLDODelisted Apr 18, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001751299

Kaleido Biosciences, Inc. was delisted on Apr 18, 2022; its insiders filed their last Form 4 on Mar 2, 2022; 63 institutions reported holding it in 13F filings for Q1 2022, worth $55.1M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Kaleido Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Kaleido Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Kaleido Biosciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Korn JeraldCOO & General Counsel4,517Mar 2, 20220
van Hylckama Vlieg JohanChief Scientific Officer4,620Mar 2, 20220
Menichella Daniel LChief Executive Officer–Jan 18, 20220
Duke William E.Chief Financial Officer–Jan 18, 20220
Long Alison SChief Medical Officer–Jan 18, 20220
Melas Kyriazi TheoDirector–Jul 1, 20210
Bonney Michael WDirector–Jul 1, 20210
Quinn Anthony G.Director–Jul 1, 20210
Mixer Jean KDirector–Jul 1, 20210
Bassler Bonnie LDirector–Jul 1, 20210
Burnett GradyDirector–Jul 1, 20210
von Maltzahn GeoffreyDirector–Jul 1, 20210
Prener AnneDirector–Jul 1, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

No insider trades match these filters.